Nu Skin Enterprises, Inc. (NUS) stock
Close on Nov 12, 2026Market cap $195.19MP/E –Yield –
Nu Skin Enterprises, Inc. saw revenue fall 15.3% to $1.32B over the twelve months to Sep 30, 2026. Free cash flow was -$26.26M, down 149.2% from a year earlier. At the latest close the market valued the company at $195.19M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $195.19M
- P/E ratio
- –
- Price to sales
- 0.15
- Price to book
- 0.36
- Dividend yield
- –
- Free cash flow yield
- -13.45%
Fundamentals
- Revenue
- $1.32B
- Net income
- -$234.21M
- EPS, diluted
- -$4.83
- Free cash flow
- -$26.26M
- Book value per share
- $11.25
- Diluted shares
- 49M
Trading
- Next earnings
- Feb 11, 2027 (estimated, during market hours)
- Previous close
- $3.89
- Open
- $3.88
- Day's range
- $3.87 – $4.03
- Volume
- 673,442
- Average volume (20 days)
- 537,213
- Index membership
- Russell 2000 (since Jun 2021), Russell 3000
- Beta (5 years)
- 0.96
- 52-week range
- $3.87 – $11.67
- RSI (14 days)
- 36.3
- Volatility (1 year)
- 45.4%
- Relative volume
- 1.23×
- WACC
- 7.7%
Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2009, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | NUS | S&P 500 | Difference | NUS per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -17.7% | -2.7% | −15.0 pts | ||
| 3 months | -16.3% | -1.7% | −14.5 pts | ||
| Year to date | -57.1% | +11.9% | −69.0 pts | ||
| 1 year | -56.7% | +12.0% | −68.7 pts | ||
| 3 years | -73.1% | +78.2% | −151.3 pts | -35.5% | +21.2% |
| 5 years | -89.5% | +73.2% | −162.7 pts | -36.2% | +11.6% |
| 10 years | -89.4% | +309.6% | −399.1 pts | -20.1% | +15.1% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Nu Skin Enterprises filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
About Nu Skin Enterprises
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Nu Skin Enterprises, Inc. develops, manufactures, and sells consumer goods focused on beauty and wellness solutions. Its primary product lines encompass beauty items, wellness products, and proprietary scanner technology. The organization operates through core business segments that include Nu Skin, manufacturing services, and the Rhyz group, including BeautyBio. Through these divisions, the enterprise provides products to end consumers and commercial partners seeking personal care, health, and manufacturing solutions.
Company profile, executives and historyNu Skin Enterprises stock: common questions
What is Nu Skin Enterprises's stock price?
NUS closed at $4.01 on Nov 12, 2026, up 3.08% on the day. Over the past 52 weeks it traded between $3.87 and $11.67.
What is Nu Skin Enterprises's market cap?
Nu Skin Enterprises was worth $195.19M at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is NUS's P/E ratio?
Nu Skin Enterprises lost money over the twelve months to Sep 30, 2026 (diluted EPS -$4.83), so it has no meaningful P/E ratio.
How much revenue does Nu Skin Enterprises make?
Nu Skin Enterprises reported revenue of $1.32B for the twelve months to Sep 30, 2026, down 15.3% from a year earlier.
Does Nu Skin Enterprises pay a dividend?
No. Nu Skin Enterprises has not paid a cash dividend over the last twelve months.
When does Nu Skin Enterprises report earnings next?
Nu Skin Enterprises is expected to report Q4 FY2026 results on Feb 11, 2027, during market hours. The date is estimated from its past reporting pattern until the company confirms it.
How has NUS stock performed over the past year?
Including dividends, NUS returned -56.7% over the past year, against +12.0% for the S&P 500.
How many NUS shares are sold short?
4M shares were sold short at the latest FINRA report, 9.68% of the float, or 11.3 days of average trading volume.
Who are Nu Skin Enterprises's competitors?
Companies most similar to Nu Skin Enterprises by business, industry and size include HLF, USNA, COSM, ASH, NATR.
See a number that looks wrong?